$116.49
2.27% (Daily)
Market Cap
$18.93B
Revenue
$13.31M
Rank by MCap
#719
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Matthew Gline
Headquarters
London, United Kingdom
Employees
750
Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.
Loading chart…